GlassScriptPhysician profile
Joel S Tupper
NPI 1427083609
$4,679.88
in general payments reported to CMS, 2019-2025
47 companies · $582 in 2025
The $582 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $29.45 · 2021: $219 · 2022: $1,833 · 2023: $947 · 2024: $720 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,248.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,318.47 | 2020-2023 | |
| Stryker Corporation | $314.92 | 2023-2025 | Mistral-Air, Aequalis Perform, Inspace |
| Corium, LLC | $239.37 | 2022-2024 | Azstarys |
| Omnilife Science, INC | $222.40 | 2024-2025 | Various Products |
| Lundbeck LLC | $203.03 | 2023-2024 | Rexulti |
| Trice Medical, INC. | $200.00 | 2019 | |
| Medacta USA, INC. | $198.14 | 2024-2025 | Gmk Sphere |
| Smith+Nephew, INC. | $178.15 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $149.85 | 2023 | Gps III Platelet Concentration System |
| Axsome Therapeutics, INC. | $146.15 | 2024-2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $138.62 | 2022-2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $135.61 | 2022-2023 | Spravato |
| Ortho Development Corporation | $125.74 | 2022 | |
| Si-Bone, INC. | $103.20 | 2021-2022 | |
| Microport Orthopedics INC | $77.01 | 2019 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nextstep Arthropedix, LLC | $59.01 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $57.57 | 2023-2025 | Iovera, Zilretta, Exparel |
| Vertex Pharmaceuticals Incorporated | $56.53 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.65 | 2023-2024 | Trintellix |
| Nevro Corp. | $50.26 | 2022-2024 | Senza |
| Exact Sciences Corporation | $44.94 | 2023-2024 | Cologuard Collection Kit |
| Depuy Synthes Sales INC. | $40.18 | 2025 | Healix Knotless Peek, Truespan Orthocord |
| Abbvie INC. | $33.98 | 2023 | Vraylar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.09 | 2022 | |
| Novo Nordisk INC | $33.01 | 2022-2023 | Rybelsus, Ozempic |
| Noven Therapeutics, LLC | $31.42 | 2023-2024 | Xelstrym |
| Amarin Pharma, INC. | $30.56 | 2022-2023 | |
| Esperion Therapeutics, INC. | $28.38 | 2022 | |
| Corcept Therapeutics | $28.31 | 2025 | Korlym |
| P Bar Medical LLC | $26.56 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $26.32 | 2022-2023 | Breztri |
| Ermi LLC | $25.25 | 2023 | |
| Baxter Healthcare | $24.75 | 2025 | Hillrom - Monarch Airway Clearance System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.65 | 2024 | Relistor |
| Sunovion Pharmaceuticals INC. | $23.28 | 2022 | |
| Daiichi Sankyo INC. | $23.10 | 2021 | |
| Antares Pharma, INC. | $19.55 | 2023 | Tlando, Xyosted, Nocdurna |
| Orthalign INC | $18.85 | 2025 | Orthalign Plus |
| Maxx Orthopedics, INC. | $18.62 | 2019 | |
| Lilly USA, LLC | $17.27 | 2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $16.94 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.85 | 2023 | Seglentis |
| Scynexis, INC. | $16.18 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.70 | 2022 | |
| Amgen INC. | $13.57 | 2024 | Prolia, Evenity |
| Paratek Pharmaceuticals, INC. | $13.55 | 2025 | Nuzyra |
| Sanofi Pasteur INC. | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Tupper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.